logo
School of Clinical Sciences
   
   
  
 

Andrew Johnson

Medical Research Technician, Faculty of Medicine & Health Sciences

Contact

Recent Publications

  • DOVLATOVA, N., WIJEYERATNE, Y.D., FOX, S.C., MANOLOPOULOS, P., JOHNSON, A.J., WHITE, A.E., LATIF, L., RALEVIC, V. and HEPTINSTALL, S., 2009. Detection of P2Y14 receptor protein on platelets and investigation of the role of P2Y14 in platelet function. J Thromb Haemostas. Supplement 2, WE-045
  • HEPTINSTALL, STAN, ESPINOSA, DAVID IYU, MANOLOPOULOS, PANAGIOTIS, GLENN, JACKIE R, WHITE, ANN E, JOHNSON, ANDREW, DOVLATOVA, NATALIA, FOX, SUE C, MAY, JANE A, HERMANN, DAVID, MAGNUSSON, OLAFUR and STEFAN, 2008. DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease. Platelets. 19(8), 605-13
  • DOVLATOVA, NATALIA, WIJEYERATNE, YANUSHI D, FOX, SUSAN C, MANOLOPOULOS, PANAGIOTIS, JOHNSON, ANDREW J, WHITE, ANN E, LATIF, M LIAQUE, RALEVIC, VERA and HEPTINSTALL, STANLEY, 2008. Detection of P2Y(14) protein in platelets and investigation of the role of P2Y(14) in platelet function in comparison with the EP(3) receptor. Thrombosis and Haemostasis. 100(2), 261-70
  • JOHNSON, A, DOVLATOVA, N and AND HEPTINSTALL, H., 2008. Multiple electrode aggregometry and P2Y12 antagonists Thrombosis and Haemostasis. 99(6), 1127-1129
  • DOVLATOVA, N., WIJEYERATNE, Y.D., FOX, S.C., MANOLOPOULOS, P., JOHNSON, A.J., WHITE, A.E., LATIF, L., RALEVIC, V. and HEPTINSTALL, S., 2009. Detection of P2Y14 receptor protein on platelets and investigation of the role of P2Y14 in platelet function. J Thromb Haemostas. Supplement 2, WE-045
  • HEPTINSTALL, STAN, ESPINOSA, DAVID IYU, MANOLOPOULOS, PANAGIOTIS, GLENN, JACKIE R, WHITE, ANN E, JOHNSON, ANDREW, DOVLATOVA, NATALIA, FOX, SUE C, MAY, JANE A, HERMANN, DAVID, MAGNUSSON, OLAFUR and STEFAN, 2008. DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease. Platelets. 19(8), 605-13
  • DOVLATOVA, NATALIA, WIJEYERATNE, YANUSHI D, FOX, SUSAN C, MANOLOPOULOS, PANAGIOTIS, JOHNSON, ANDREW J, WHITE, ANN E, LATIF, M LIAQUE, RALEVIC, VERA and HEPTINSTALL, STANLEY, 2008. Detection of P2Y(14) protein in platelets and investigation of the role of P2Y(14) in platelet function in comparison with the EP(3) receptor. Thrombosis and Haemostasis. 100(2), 261-70
  • JOHNSON, A, DOVLATOVA, N and AND HEPTINSTALL, H., 2008. Multiple electrode aggregometry and P2Y12 antagonists Thrombosis and Haemostasis. 99(6), 1127-1129
  • HEPTINSTALL, S., FOX, S., GLENN, J., JOHNSON, A., WHITE, A., HATZINOCOLAU, M., PINK, A., STAFFORD, N., BEHAN, M., DOLAN, G. and AND MYERS, B., 2007. Leucocytes influence platelet aggregation more than you think Platelets. 18(1), 77-78
  • WHITE, A., GLENN, J., FOX, S., JOHNSON, A., MYERS, B. and AND HEPTINSTALL, S., 2007. Reduced platelet aggregation to ADP and ATP in patients with leucocytosis is due to enhanced rates of adenine nucleotide metabolism mediated by the NTPDase CD39 Platelets. 18(1), 100
  • HEPTINSTALL, S, MYERS, B, FOX, S.C, GLENN, J.R, JOHNSON, A.J and AND WHITE, A.E., 2007. Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis. Journal of Thrombosis and Haemostasis: JTH. 5(Supplement 2), P-W-356
  • HEPTINSTALL, S, MYERS, B, FOX, S.C, GLENN, J.R and JOHNSON, A.J. AND WHITE, A.E., 2007. Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis. Thrombosis Research. 120(Supplement 2), S153-S154
  • HEPTINSTALL, S., FOX, S., GLENN, J., JOHNSON, A., WHITE, A., HATZINOCOLAU, M., PINK, A., STAFFORD, N., BEHAN, M., DOLAN, G. and MYERS, B., 2006. Effects of blood leucocytes on platelet aggregation - a review of recent studies on leucocytes, adenine nucleotide metabolism and CD39 Seminars in Cardiology. 12(2), 43-54
  • HEPTINSTALL, STAN, GLENN, JACQUELINE R, JOHNSON, ANDREW, MYERS, BETHAN, WHITE, ANN E and ZHAO, LIAN, 2006. Leukocytosis, vascular disease, and adenine nucleotide metabolism. Arteriosclerosis, Thrombosis, and Vascular Biology. 26(2), e22-3
  • HEPTINSTALL, S., GLENN, J.R., JOHNSTON, A., WHITE, A. and MYERS, B., 2006. Leucocytes, leucocytosis and adenine nucleotide metabolism. Platelets. 17, 115
  • HEPTINSTALL, S., FOX, S.C., GLENN, J.R., JOHNSON, A., WHITE, A.E., DOLAN, G. and MYERS, B., 2006. Blood leucocytes are mobile modulators of adenine metabolism and play an important role in determining the effects of adenine nucleotides on platelet function. Purinergic Signalling. 2, 137
  • GLENN, JACQUELINE R, WHITE, ANN E, JOHNSON, ANDREW, FOX, SUSAN C, BEHAN, MILES W H, DOLAN, GERRY and HEPTINSTALL, STANLEY, 2005. Leukocyte count and leukocyte ecto-nucleotidase are major determinants of the effects of adenosine triphosphate and adenosine diphosphate on platelet aggregation in human blood. Platelets. 16(3-4), 159-70
  • JOHNSON, A.J., 2005. Contribution of blood cells to adenine nucleotide metabolism. In: International Society of Thrombosis & Haemostasis, Sydney 2005. P2134
  • RAO, A., GEORGIADOU, P., JOHNSON, A., FRANCIS, D.P., SIMONDS, A.K., COATS, A.J., COWLEY, A.J. and MORRELL, A., 2003. The prevalence of sleep disordered breathing in a UK heart failure clinic population and its relation to urinary catecholamines. Heart. 89(4.(suppl 1 May 2003)),

School of Clinical Sciences

D Floor, East Block
Queen's Medical Centre
Nottingham, NG7 2UH

telephone: +44 (0) 115 823 0695
fax: +44 (0) 115 823 0704
email: scs-enquiries@nottingham.ac.uk